Evaluation of an implantable ventricular assist system for humans with chronic refractory heart failure: patient selection

D. Glenn Pennington; Bartley P. Griffith; Marc T. Swartz; Sonja M. McKinlay; Peer M. Portner; Michael J. Domanski; John T. Watson

doi:10.1097/00002480-199501000-00005

Evaluation of an implantable ventricular assist system for humans with chronic refractory heart failure: patient selection

D. Glenn Pennington, Bartley P. Griffith, Marc T. Swartz, Sonja M. McKinlay, Peer M. Portner, Michael J. Domanski, John T. Watson

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

From the estimated number of candidate patients for heart transplantation at a maximum of 60,000 per year, only 2,000 receive a transplant due to inherent factors involving advanced age and the coexistence of some diseases. The primary objective of this study is to show the feasibility of implanting LVAS in 20 patients for a period of two years. LVAS recipients in this study is not limited to a population of patients who would have been excluded from transplantation due to the stated factors. Like wise the study is not designed to evaluate the LVAS only in patients who are transplant candidates. Although the clinical arm of this trial has not been tested, it is hoped that the study presented will be useful in preparation for future studies.

Original language	English
Pages (from-to)	23-26
Number of pages	4
Journal	ASAIO Journal
Volume	41
Issue number	1
DOIs	https://doi.org/10.1097/00002480-199501000-00005
State	Published - 1995
Externally published	Yes

Access to Document

10.1097/00002480-199501000-00005

Cite this

@article{ad8e88a2452c4ee1a5bfcd6d5647d06d,

title = "Evaluation of an implantable ventricular assist system for humans with chronic refractory heart failure: patient selection",

abstract = "From the estimated number of candidate patients for heart transplantation at a maximum of 60,000 per year, only 2,000 receive a transplant due to inherent factors involving advanced age and the coexistence of some diseases. The primary objective of this study is to show the feasibility of implanting LVAS in 20 patients for a period of two years. LVAS recipients in this study is not limited to a population of patients who would have been excluded from transplantation due to the stated factors. Like wise the study is not designed to evaluate the LVAS only in patients who are transplant candidates. Although the clinical arm of this trial has not been tested, it is hoped that the study presented will be useful in preparation for future studies.",

author = "Pennington, {D. Glenn} and Griffith, {Bartley P.} and Swartz, {Marc T.} and McKinlay, {Sonja M.} and Portner, {Peer M.} and Domanski, {Michael J.} and Watson, {John T.}",

year = "1995",

doi = "10.1097/00002480-199501000-00005",

language = "English",

volume = "41",

pages = "23--26",

journal = "ASAIO Journal",

issn = "1058-2916",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Evaluation of an implantable ventricular assist system for humans with chronic refractory heart failure

T2 - patient selection

AU - Pennington, D. Glenn

AU - Griffith, Bartley P.

AU - Swartz, Marc T.

AU - McKinlay, Sonja M.

AU - Portner, Peer M.

AU - Domanski, Michael J.

AU - Watson, John T.

PY - 1995

Y1 - 1995

N2 - From the estimated number of candidate patients for heart transplantation at a maximum of 60,000 per year, only 2,000 receive a transplant due to inherent factors involving advanced age and the coexistence of some diseases. The primary objective of this study is to show the feasibility of implanting LVAS in 20 patients for a period of two years. LVAS recipients in this study is not limited to a population of patients who would have been excluded from transplantation due to the stated factors. Like wise the study is not designed to evaluate the LVAS only in patients who are transplant candidates. Although the clinical arm of this trial has not been tested, it is hoped that the study presented will be useful in preparation for future studies.

AB - From the estimated number of candidate patients for heart transplantation at a maximum of 60,000 per year, only 2,000 receive a transplant due to inherent factors involving advanced age and the coexistence of some diseases. The primary objective of this study is to show the feasibility of implanting LVAS in 20 patients for a period of two years. LVAS recipients in this study is not limited to a population of patients who would have been excluded from transplantation due to the stated factors. Like wise the study is not designed to evaluate the LVAS only in patients who are transplant candidates. Although the clinical arm of this trial has not been tested, it is hoped that the study presented will be useful in preparation for future studies.

UR - http://www.scopus.com/inward/record.url?scp=0029193318&partnerID=8YFLogxK

U2 - 10.1097/00002480-199501000-00005

DO - 10.1097/00002480-199501000-00005

M3 - Article

C2 - 7727818

AN - SCOPUS:0029193318

SN - 1058-2916

VL - 41

SP - 23

EP - 26

JO - ASAIO Journal

JF - ASAIO Journal

IS - 1

ER -

Evaluation of an implantable ventricular assist system for humans with chronic refractory heart failure: patient selection

Abstract

Access to Document

Fingerprint

Cite this